TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35895571

Group type: EXPERIMENTAL
Intervention: Multimodal aerobic and strength exercises programs (6 weeks of supervised intermittent aerobic cycling, home‐based walking, isometric and electrical muscle stimulation (EMS) exercise training)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study: 34814738

Group type: EXPERIMENTAL
Intervention: PROMISE intervention
Number of subjects: 12000
Study: 35487751

Group type: EXPERIMENTAL
Intervention: 12 weeks of Frame Running training two times weekly for 60 min
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 62
Study: 34005909

Group type: EXPERIMENTAL
Intervention: Articulation point probabilities in complex networks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bredge probabilities in complex networks
Number of subjects: 0
Study: 34489161

Group type: EXPERIMENTAL
Intervention: Nivolumab plus concurrent chemoradiotherapy (cCRT) followed by nivolumab with ipilimumab (Arm A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nivolumab alone (Arm B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy followed by durvalumab (Arm C)
Number of subjects: 0
Study: 33303397

Group type: EXPERIMENTAL
Intervention: AL method
Number of subjects: 32
Study: 33973655

Group type: EXPERIMENTAL
Intervention: 40 mg/kg intravenous dose of raxibacumab over a period of 2.25 hours
Number of subjects: 322
Study: 32886915

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP) placement
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Aggressive intra-arterial endovascular treatment for vasospasm
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Non-aggressive treatment for vasospasm
Number of subjects: 1096
Study: 35750735

Group type: EXPERIMENTAL
Intervention: Mobile app clinical decision support tools (CDST)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Print CDST
Number of subjects: 0

Group type: COMPARATOR
Intervention: No CDST
Number of subjects: 0
Study: 34343327

Group type: EXPERIMENTAL
Intervention: Pressure Pain Threshold (PPT) over the median nerve
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Function
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pressure Pain Threshold (PPT) over the carpal tunnel
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pressure Pain Threshold (PPT) over the tibialis anterior
Number of subjects: 120
Study: 33127291

Group type: EXPERIMENTAL
Intervention: Respiratory muscle training (RMT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham-RMT
Number of subjects: 22
Study: 35191289

Group type: EXPERIMENTAL
Intervention: RST with CoD (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: RST without CoD (n = 10)
Number of subjects: 20
Study: 33744640

Group type: EXPERIMENTAL
Intervention: Whole grain consumption (50% of grain servings from whole grain foods daily for 6 weeks)
Number of subjects: 44
Study: 35610353

Group type: EXPERIMENTAL
Intervention: Structured Water Dance Intervention (SWAN), administered for 40 min once a week during a 12-week period.
Number of subjects: 34
Study: 33106354

Group type: EXPERIMENTAL
Intervention: Autologous faecal microbiota transplantation (FMT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy donor faecal microbiota transplantation (FMT)
Number of subjects: 20
Study: 36145157

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (1600 IU/day)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 34589204

Group type: EXPERIMENTAL
Intervention: Inulin-type fructans (16 g/d)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (maltodextrin)
Number of subjects: 35
Study: 36034299

Group type: EXPERIMENTAL
Intervention: 5 Hz rTMS stimulation to the affected mylohyoid cortical region
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 5 Hz rTMS
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Right rTMS
Number of subjects: 49
Study: 33345430

Group type: EXPERIMENTAL
Intervention: Insufficient 25(OH)D levels (<20 ng/mL)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Relatively insufficient 25(OH)D levels (20–<30 ng/mL)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Sufficient 25(OH)D levels (≥30 ng/mL)
Number of subjects: 422
Study: 36217795

Group type: EXPERIMENTAL
Intervention: D. esculenta (300 mg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 36055877

Group type: EXPERIMENTAL
Intervention: Pfizer mRNA COVID-19 vaccine
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Moderna mRNA COVID-19 vaccine
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Combined mRNA vaccines (Pfizer and Moderna)
Number of subjects: 2
Study: 33831046

Group type: EXPERIMENTAL
Intervention: Tocilizumab 400 mg
Number of subjects: 107
Study: 34344266

Group type: EXPERIMENTAL
Intervention: Music therapy during Nonstress Test
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 100
Study: 33119467

Group type: EXPERIMENTAL
Intervention: 150 mg of fluconazole (EDHF inhibition)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 500 mg of aspirin (prostaglandin inhibition)
Number of subjects: 18

Group type: COMPARATOR
Intervention: maltodextrin (control)
Number of subjects: 18
Study: 32841825

Group type: EXPERIMENTAL
Intervention: CrossFit Kids (CFK) program
Number of subjects: 144

Group type: COMPARATOR
Intervention: PE class
Number of subjects: 144
Study: 36180816

Group type: EXPERIMENTAL
Intervention: Dispersible Pretomanid Tablets (DTF) 10 mg, 50 mg, 200 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Marketed Formulation (MF) 200 mg
Number of subjects: 48
Study: 34786998

Group type: EXPERIMENTAL
Intervention: Prediction model based on total prostate-specific antigen, clinical tumor stage, Gleason score, prostate volume, red cell distribution width, and serum alkaline phosphatase.
Number of subjects: 332
Study: 32403062

Group type: EXPERIMENTAL
Intervention: Positive appearance comment
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Reality check comment plus positive appearance comment
Number of subjects: 192

Group type: COMPARATOR
Intervention: No comment
Number of subjects: 192
Study: 33516927

Group type: EXPERIMENTAL
Intervention: Indomethacin (IM) oral spray
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 60
Study: 34454563

Group type: EXPERIMENTAL
Intervention: Web-based educational intervention for general practitioners
Number of subjects: 120
Study: 32855160

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM) with Dexcom G6
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 110
Study: 33156414

Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 24

Group type: COMPARATOR
Intervention: Concentric exercise
Number of subjects: 24
Study: 35236061

Group type: EXPERIMENTAL
Intervention: Transcranial magnet therapy (TMT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low-frequency magnet therapy
Number of subjects: 50
Study: 33709991

Group type: EXPERIMENTAL
Intervention: Patient-derived tumor organoid culture model
Number of subjects: 71
Study: 32898990

Group type: EXPERIMENTAL
Intervention: Educated group (nurses with enhanced education)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (nurses without enhanced education)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Educated group
Number of subjects: 190
Study: 35069808

Group type: EXPERIMENTAL
Intervention: FOLFIRI
Number of subjects: 172

Group type: COMPARATOR
Intervention: irinotecan
Number of subjects: 172
Study: 33470748

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo/sham controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SCS-specific safety outcomes
Number of subjects: 0
Study: 33508780

Group type: EXPERIMENTAL
Intervention: Eccentric-overload training
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: All training groups (except in-water-specific strength training)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: All training groups
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: All training groups (except dry-land strength training)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: All training groups (except in-water-specific strength training and ballistic training)
Number of subjects: 56
Study: 36273491

Group type: EXPERIMENTAL
Intervention: AZD1222 (ChAdOx1 nCoV-19) vaccine
Number of subjects: 185
Study: 34412797

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 758
Study: 32462773

Group type: EXPERIMENTAL
Intervention: Zonisamide (400 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 35419078

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no acupuncture treatment)
Number of subjects: 39
Study: 33555830

Group type: EXPERIMENTAL
Intervention: Oral contraceptive (OC) users
Number of subjects: 21
Study: 35419610

Group type: EXPERIMENTAL
Intervention: Manipulation under anesthesia (MUA)
Number of subjects: 391

Group type: COMPARATOR
Intervention: No MUA
Number of subjects: 391
Study: 35513795

Group type: EXPERIMENTAL
Intervention: Low-25(OH)D-Calcitriol group (calcitriol 0.25 µg bid)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-25(OH)D-Calcitriol group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-25(OH)D group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-25(OH)D-Calcitriol group and Normal-25(OH)D group
Number of subjects: 30
Study: 32852352

Group type: EXPERIMENTAL
Intervention: MenACYW-TT
Number of subjects: 1000

Group type: COMPARATOR
Intervention: MenACWY-CRM
Number of subjects: 1000
Study: 35316080

Group type: EXPERIMENTAL
Intervention: Capecitabine (1,250 mg/m2 twice daily on days 1‐14 of a 21‐day cycle, for eight cycles)
Number of subjects: 447

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Capecitabine (adjusted for minimization factors, nodal status, grade, and sex)
Number of subjects: 447
Study: 616664553

Group type: EXPERIMENTAL
Intervention: Visual-Scanning Training (VST)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prismatic Adaptation (PA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 20
Study: 34651477

Group type: EXPERIMENTAL
Intervention: RATKA group (robot-assisted TKA using YUANHUA-TKA system)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional TKA group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (RATKA and traditional TKA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: RATKA group
Number of subjects: 60
Study: 36208548

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT), 40 daily sessions
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 73
Study: 33556104

Group type: EXPERIMENTAL
Intervention: Condom-catheter uterine balloon tamponade (UBT)
Number of subjects: 2246

Group type: COMPARATOR
Intervention: No UBT
Number of subjects: 2246

Group type: EXPERIMENTAL
Intervention: Overall care satisfaction
Number of subjects: 2246

Group type: EXPERIMENTAL
Intervention: Care aspects liked least
Number of subjects: 2246
Study: 33307554

Group type: EXPERIMENTAL
Intervention: High-intensity inspiratory muscle training at 80% of maximal inspiratory pressure, 3 sets of 12 repetitions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-intensity inspiratory muscle training at 50% of maximal inspiratory pressure, 2 sets of 20 repetitions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no inspiratory muscle training)
Number of subjects: 0
Study: 32441658

Group type: EXPERIMENTAL
Intervention: Do CHANGE intervention (3-month behavioral program with ecological momentary assessment and intervention technologies)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Do CHANGE intervention
Number of subjects: 149
Study: 36064261

Group type: EXPERIMENTAL
Intervention: Simplified Culture System (SCS)
Number of subjects: 653

Group type: COMPARATOR
Intervention: Intracytoplasmic Sperm Injection (ICSI)
Number of subjects: 653
Study: 32798096

Group type: EXPERIMENTAL
Intervention: Texting their friend
Number of subjects: 130

Group type: COMPARATOR
Intervention: No activity condition
Number of subjects: 130

Group type: COMPARATOR
Intervention: Passive-phone condition
Number of subjects: 130
Study: 35944412

Group type: EXPERIMENTAL
Intervention: Oral contraceptive (OC) users
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Temperature at 40 °C
Number of subjects: 27

Group type: COMPARATOR
Intervention: Menstrual cycle (MC)
Number of subjects: 27
Study: 34468701

Group type: COMPARATOR
Intervention: Laparoscopic Gastrectomy (LG)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Robotic Gastrectomy (RG)
Number of subjects: 241
Study: 35394687

Group type: EXPERIMENTAL
Intervention: Spirulina (5.7 g day-1)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (isoproteic and caloric)
Number of subjects: 17
Study: 33835329

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS) 400ml (400kcal) per day for 12 weeks
Number of subjects: 1003

Group type: COMPARATOR
Intervention: Control group (regular diet)
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS) for patients taking more than 200ml/day
Number of subjects: 1003
Study: 32780315

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 1200

Group type: COMPARATOR
Intervention: EQ-5D-3L
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L and EQ-5D-3L
Number of subjects: 1200
Study: 34351576

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 3032

Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 3032
Study: 32054669

Group type: EXPERIMENTAL
Intervention: ApoCIII-Lp(a) complexes
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: OxPL-apoB and OxPL-apo(a)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Autotaxin (ATX) on ApoB and ATX on Lp(a)
Number of subjects: 218
Study: 35171199

Group type: EXPERIMENTAL
Intervention: Increased adjusted NT-proBNP levels at year 1
Number of subjects: 1644

Group type: COMPARATOR
Intervention: Normal NT-proBNP levels at year 1
Number of subjects: 1644
Study: 34814585

Group type: EXPERIMENTAL
Intervention: 60 μg hepatitis B vaccine
Number of subjects: 249

Group type: COMPARATOR
Intervention: 20 μg hepatitis B vaccine
Number of subjects: 249
Study: 33176308

Group type: EXPERIMENTAL
Intervention: Higher prestroke Physical Activity (PA) as measured by the Physical Activity Scale for the Elderly (PASE) in quartiles (2nd, 3rd, and 4th)
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Higher prestroke PA (quartiles 2nd, 3rd, and 4th)
Number of subjects: 625
Study: 36436613

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ambient air
Number of subjects: 90
Study: 32597821

Group type: EXPERIMENTAL
Intervention: Social security hospitals
Number of subjects: 938

Group type: COMPARATOR
Intervention: Private hospitals
Number of subjects: 938

Group type: COMPARATOR
Intervention: Public hospitals
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: Blood management
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: Safe drug management, error management, infection control, safe clinical services
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: Management and leadership of patient safety
Number of subjects: 938
Study: 32449452

Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention
Number of subjects: 111
Study: 32940428

Group type: EXPERIMENTAL
Intervention: Telemedicine (TM) service based on mobile health (mHealth), including remote daily monitoring of biometric data and symptom reporting combined with videoconference structured, nurse-based follow-up.
Number of subjects: 508

Group type: COMPARATOR
Intervention: Usual care (UC) strategy based on face-to-face on-site visits.
Number of subjects: 508
Study: 35618364

Group type: EXPERIMENTAL
Intervention: Rock & Water social emotional learning intervention
Number of subjects: 1299
Study: 34211390

Group type: EXPERIMENTAL
Intervention: Model-Based Working Memory Training with distractor inhibition (MB+)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Model-Based Working Memory Training without distractor inhibition (MB)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Dual n-back training
Number of subjects: 123

Group type: COMPARATOR
Intervention: Active control training
Number of subjects: 123
Study: 33565339

Group type: EXPERIMENTAL
Intervention: Artificial hair implantation using biocompatible fibers (Biofibre®, Nido Z‐type)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 34065698

Group type: EXPERIMENTAL
Intervention: Virtual Reality-Based Cognitive Stimulation (10 sessions over 2 months, 2 sessions/week)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 17
Study: 32745938

Group type: EXPERIMENTAL
Intervention: Fluorescence spectroscopy at 450 nm excitation wavelength
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluorescence spectroscopy at 385 nm and 405 nm excitation wavelengths
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diffuse reflectance spectroscopy (DRS) measurements
Number of subjects: 0
Study: 35654307

Group type: EXPERIMENTAL
Intervention: Entire Supraclavicular Nodal Irradiation (E-SCLI)
Number of subjects: 544

Group type: COMPARATOR
Intervention: Medial Supraclavicular Nodal Irradiation (M-SCLI)
Number of subjects: 544
Study: 33787615

Group type: EXPERIMENTAL
Intervention: Pilates group (P-G)
Number of subjects: 41

Group type: COMPARATOR
Intervention: General physical activity program group (Pa-G)
Number of subjects: 41
Study: 35623841

Group type: EXPERIMENTAL
Intervention: 6.3 g (Low) essential amino acid enriched whey protein supplement
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 12.6 g (High) essential amino acid enriched whey protein supplement
Number of subjects: 8
Study: 34240694

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 10
Study: 35685534

Group type: EXPERIMENTAL
Intervention: Probiotics (1.8 × 10^9 CFU/day)
Number of subjects: 70
Study: 32507383

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 1

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 1
Study: 35773956

Group type: EXPERIMENTAL
Intervention: Supportive Parenting App (SPA)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 33
Study: 33757875

Group type: EXPERIMENTAL
Intervention: TBscore intervention
Number of subjects: 3571
Study: 34586711

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (dose ≤1,000 mg/day)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Curcumin supplementation (>10-week intervention)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Curcumin consumption (less than 2000 mg/day)
Number of subjects: 9
Study: 34953926

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 0
Study: 33434288

Group type: EXPERIMENTAL
Intervention: Incorporating selected metabolites (27 identified metabolites) into fracture risk prediction models.
Number of subjects: 1552

Group type: EXPERIMENTAL
Intervention: Selected metabolites from the glycine, serine, and threonine metabolism pathway (creatine, dimethylglycine, glycine, and serine).
Number of subjects: 1552

Group type: EXPERIMENTAL
Intervention: Causally related metabolites (glycine, phosphatidylcholine [PC], and triacylglycerol [TAG]).
Number of subjects: 1552
Study: 34402121

Group type: EXPERIMENTAL
Intervention: Instant message-based lifestyle and stress management intervention for 5 months
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (no instant message intervention)
Number of subjects: 164
Study: 33285707

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-propofol combination (Group D)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ketamine-propofol combination (Group K)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 33743777

Group type: EXPERIMENTAL
Intervention: Remote knowledge broker offering tailored support via phone and email (group A)
Number of subjects: 2765

Group type: COMPARATOR
Intervention: Generalised monthly email focused on tobacco and depression treatment (group B)
Number of subjects: 2765

Group type: EXPERIMENTAL
Intervention: Cost minimisation analysis
Number of subjects: 2765
Study: 34131942

Group type: EXPERIMENTAL
Intervention: 50 mg Omecamtiv mecarbil (OM)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 400 mg moxifloxacin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34560383

Group type: EXPERIMENTAL
Intervention: Cisplatin 30 mg/m2 with nimotuzumab once a week with curative radiotherapy
Number of subjects: 536

Group type: COMPARATOR
Intervention: Cisplatin 30 mg/m2 alone
Number of subjects: 536
Study: 33591290

Group type: EXPERIMENTAL
Intervention: mHealth behavior change intervention (educational sessions and 8-week physical activity goal setting using Fitbit and SMS)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: mHealth behavior change intervention
Number of subjects: 49
Study: 32868698

Group type: EXPERIMENTAL
Intervention: Localized heating on postoperative days 3 and 4
Number of subjects: 58

Group type: COMPARATOR
Intervention: Normothermia without localized heating
Number of subjects: 58
Study: 35157136

Group type: EXPERIMENTAL
Intervention: iPACK + ACB
Number of subjects: 105

Group type: COMPARATOR
Intervention: PAI + ACB
Number of subjects: 105

Group type: COMPARATOR
Intervention: ACB
Number of subjects: 105
Study: 34243388

Group type: EXPERIMENTAL
Intervention: New, improved CECE coherency‐based analysis for calculating temperature fluctuation frequency spectrum and level
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New method for calculating noise levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct calculation of system noise level using correlation between randomized intermediate frequency signals
Number of subjects: 0